Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arbuckle, M R
Right arrow Articles by Harley, J B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arbuckle, M R
Right arrow Articles by Harley, J B
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 12, No. 2, 99-106 (2003)
DOI: 10.1191/0961203303lu334oa

Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus

M R Arbuckle

Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA

J A James

Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA, Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA, jamesj{at}omrf.ouhsc.edu

G J Dennis

Department of Rheumatology, Walter Reed Army Medical Center, Washington, DC, USA

M V Rubertone

Army Medical Surveillance Activity, US Army Center for Health Promotion and Preventive Medicine, Washington, DC, USA

M T McClain

Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA, Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

X R Kim

Genetic Epidemiology Unit, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA

J B Harley

Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA, Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA, US Department of Veterans Affairs, Oklahoma City, Oklahoma, USA

The initial clinical course of systemic lupus erythematosus (SLE) is variable, ranging from relatively minor manifestations progressing over years to rapid onset of fulminate disease. We sought to identify factors associated with the rapid manifestation of SLE. Chart review of military medical records was used to identify 130 patients who met the American College of Rheumatology classification criteria for SLE. Demographics, clinical criteria date of occurrence, and the date of SLE classification (at least four clinical criteria) met were documented. Prospectively stored serum samples prior to the diagnosis were evaluated for SLE autoantibodies. Median time from the first recorded criteria to diagnosis was significantly shorter in African-American (AA) males compared with AA females and European American (EA) females and males combined. AA males were more likely to have nephritis as their first clinical symptom. Also, less time transpired between the first clinical criterion and SLE diagnosis in AA males with nephritis than in other groups presenting with nephritis. Even when cases presenting with nephritis were excluded, a diagnosis of SLE was made more rapidly in AA males. African-American men progress from initial clinical manifestations to SLE diagnosis more rapidly than other ethnic or gender groups.

Key Words: African-American • autoantibodies • ethnicity • gender • lupus • SLE


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
C Lebrun, M Debouverie, S Jeannin, S Pittion-Vouyovitch, C Bayreuther, and F Berthier
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France
Multiple Sclerosis, August 1, 2008; 14(7): 933 - 939.
[Abstract] [PDF]


Home page
LupusHome page
F. Burling, J. Ng, H. Thein, J. Ly, M.R. Marshall, and P. Gow
Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort
Lupus, October 1, 2007; 16(10): 830 - 837.
[Abstract] [PDF]


Home page
Mult SclerHome page
R T Naismith, K Trinkaus, and A H Cross
Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review
Multiple Sclerosis, November 1, 2006; 12(6): 775 - 781.
[Abstract] [PDF]


Home page
J. Immunol.Home page
G. Rai, S. Ray, R. E. Shaw, P. F. DeGrange, R. G. Mage, and B. A. Newman
Models of Systemic Lupus Erythematosus: Development of Autoimmunity Following Peptide Immunizations of Noninbred Pedigreed Rabbits
J. Immunol., January 1, 2006; 176(1): 660 - 667.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M A Garcia, J C Marcos, A I Marcos, B A Pons-Estel, D Wojdyla, A Arturi, J C Babini, L J Catoggio, and D Alarcon-Segovia
Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients
Lupus, December 1, 2005; 14(12): 938 - 946.
[Abstract] [PDF]


Home page
LupusHome page
L J Jara, G Medina, O Vera-Lastra, and L Barile
The impact of gender on clinical manifestations of primary antiphospholipid syndrome
Lupus, August 1, 2005; 14(8): 607 - 612.
[Abstract] [PDF]